Skip to main content
Clinical Trials/JPRN-UMIN000018069
JPRN-UMIN000018069
Recruiting
N/A

The clinical trial to examine the efficacy of the intravitreal injection of anti-VEGF antibody Bevacizumab(Avastin) for severe retinopathy of prematurity. - The clinical trial to examine the efficacy of the intravitreal injection of Bevacizumab for severe ROP.

Gunma University Hospital Department of Ophthalmology0 sites4 target enrollmentJune 24, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Retinopathy of prematurity
Sponsor
Gunma University Hospital Department of Ophthalmology
Enrollment
4
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 24, 2017
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Gunma University Hospital Department of Ophthalmology

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)The patient who judged inappropriate as a subject by pediatrician. 2\)In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

Outcomes

Primary Outcomes

Not specified

Similar Trials